These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy]. Maron MS Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172 [TBL] [Abstract][Full Text] [Related]
27. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]. Maron BJ; Spirito P Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):297-302. PubMed ID: 19791462 [TBL] [Abstract][Full Text] [Related]
28. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286 [TBL] [Abstract][Full Text] [Related]
29. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826 [TBL] [Abstract][Full Text] [Related]
33. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P J Am Coll Cardiol; 2020 Dec; 76(25):e159-e240. PubMed ID: 33229116 [No Abstract] [Full Text] [Related]
34. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. Alcalai R; Seidman JG; Seidman CE J Cardiovasc Electrophysiol; 2008 Jan; 19(1):104-10. PubMed ID: 17916152 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol. Ng CT; Chee TS; Ling LF; Lee YP; Ching CK; Chua TS; Cheok C; Ong HY Europace; 2011 Jun; 13(6):883-8. PubMed ID: 21486912 [TBL] [Abstract][Full Text] [Related]
37. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ; Spirito P J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577 [TBL] [Abstract][Full Text] [Related]
38. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients. Maron BJ; Yacoub M; Dearani JA Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444 [TBL] [Abstract][Full Text] [Related]
40. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]